Development of an acellular tumor extracellular matrix as a three-dimensional scaffold for tumor engineering

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Lü, Wei Dong ^a   Zhang, Lei ^b   Wu, Chun Lin ^c   Liu, Zhi Gang ^a   Lei, Guang Yan ^a   Liu, Jia ^a   Gao, Wei ^a   Hu, Ye Rong ^c  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CYTOKERATIN 7; COLLAGEN; DNA; DODECYL SULFATE SODIUM; DRUG COMBINATION; GLYCOSAMINOGLYCAN; LAMININ; MATRIGEL; PROTEOGLYCAN; SIGNAL PEPTIDE; TRYPSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIOENGINEERING; BIOMECHANICS; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; POROSITY; THREE DIMENSIONAL IMAGING; TISSUE ENGINEERING; TUMOR MICROENVIRONMENT; ANIMAL; CELL SURVIVAL; CHEMISTRY; CULTURE TECHNIQUE; DRUG COMBINATION; MCF 7 CELL LINE; METABOLISM; TISSUE SCAFFOLD; TUMOR CELL LINE; XENOGRAFT; YOUNG MODULUS;

ANIMALS; BIOMECHANICAL PHENOMENA; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SURVIVAL; COLLAGEN; DNA, NEOPLASM; DRUG COMBINATIONS; ELASTIC MODULUS; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LAMININ; MCF-7 CELLS; MICE; POROSITY; PROTEOGLYCANS; SODIUM DODECYL SULFATE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSPLANTATION, HETEROLOGOUS; TRYPSIN;

EID: 84904961478     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103672     Document Type: Article

References (53)

1. Nyga A, Cheema U, Loizidou M (2011) 3D tumour models: novel in vitro approaches to cancer studies. J Cell Commun Signal 5: 239-248.
2. Szot CS, Buchanan CF, Freeman JW, Rylander MN (2011) 3D in vitro bioengineered tumors based on collagen I hydrogels. Biomaterials 32: 7905-7912.
3. Kagadis GC, Loudos G, Katsanos K, Langer SG, Nikiforidis GC (2010) In vivo small animal imaging: current status and future prospects. Med Phys 37: 6421-6442.
4. Yamada KM, Cukierman E (2007) Modeling tissue morphogenesis and cancer in 3D. Cell 130: 601-610. (Pubitemid 47268064)
5. Hutmacher DW, Loessner D, Rizzi S, Kaplan DL, Mooney DJ, et al. (2010) Can tissue engineering concepts advance tumor biology research? Trends Biotechnol 28: 125-133.
6. Fischbach C, Chen R, Matsumoto T, Schmelzle T, Brugge JS, et al. (2007) Engineering tumors with 3D scaffolds. Nat Methods 4: 855-860. (Pubitemid 350055585)
7. Verbridge SS, Choi NW, Zheng Y, Brooks DJ, Stroock AD, et al. (2010) Oxygen-controlled three-dimensional cultures to analyze tumor angiogenesis. Tissue Eng Part A 16: 2133-2141.
8. Fong EL, Lamhamedi-Cherradi SE, Burdett E, Ramamoorthy V, Lazar AJ, et al. (2013) Modeling Ewing sarcoma tumors in vitro with 3D scaffolds. Proc Natl Acad Sci U S A 110: 6500-6505.
9. Nyga A, Loizidou M, Emberton M, Cheema U (2013) A novel tissue engineered three-dimensional in vitro colorectal cancer model. Acta Biomater 9: 7917-7926.
10. Ghajar CM, Bissell MJ (2010) Tumor engineering: the other face of tissue engineering. Tissue Eng Part A 16: 2153-2156.
11. Tilghman RW, Blais EM, Cowan CR, Sherman NE, Grigera PR, et al. (2012) Matrix rigidity regulates cancer cell growth by modulating cellular metabolism and protein synthesis. PLoS One 7: e37231.
12. Caicedo-Carvajal CE, Liu Q, Remache Y, Goy A, Suh KS (2011) Cancer Tissue Engineering: A Novel 3D Polystyrene Scaffold for In Vitro Isolation and Amplification of Lymphoma Cancer Cells from Heterogeneous Cell Mixtures. J Tissue Eng 2011: 362326.
13. Gill BJ, Gibbons DL, Roudsari LC, Saik JE, Rizvi ZH, et al. (2012) A synthetic matrix with independently tunable biochemistry and mechanical properties to study epithelial morphogenesis and EMT in a lung adenocarcinoma model. Cancer Res 72: 6013-6023.
14. Sahoo SK, Panda AK, Labhasetwar V (2005) Characterization of porous PLGA/PLA microparticles as a scaffold for three dimensional growth of breast cancer cells. Biomacromolecules 6: 1132-1139. (Pubitemid 40467862)
15. Barkan D, Kleinman H, Simmons JL, Asmussen H, Kamaraju AK, et al. (2008) Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res 68: 6241-6250.
16. Harma V, Virtanen J, Makela R, Happonen A, Mpindi JP, et al. (2010) A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS One 5: e10431.
17. Gurski LA, Jha AK, Zhang C, Jia X, Farach-Carson MC (2009) Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. Biomaterials 30: 6076-6085.
18. Godugu C, Patel AR, Desai U, Andey T, Sams A, et al. (2013) AlgiMatrix based 3D cell culture system as an in-vitro tumor model for anticancer studies. PLoS One 8: e53708.
19. Leung M, Kievit FM, Florczyk SJ, Veiseh O, Wu J, et al. (2010) Chitosan-alginate scaffold culture system for hepatocellular carcinoma increases malignancy and drug resistance. Pharm Res 27: 1939-1948.
20. Baker BM, Chen CS (2012) Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci 125: 3015-3024.
21. Gilbert TW, Sellaro TL, Badylak SF (2006) Decellularization of tissues and organs. Biomaterials 27: 3675-3683.
22. Hoshiba T, Lu H, Kawazoe N, Chen G (2010) Decellularized matrices for tissue engineering. Expert Opin Biol Ther 10: 1717-1728.
23. Feldman JP, Goldwasser R, Mark S, Schwartz J, Orion I (2009) A mathematical model for tumor volume evaluation using two-Dimensions. J Appl Quant Methods 4: 455-462.
24. Yang B, Zhang Y, Zhou L, Sun Z, Zheng J, et al. (2010) Development of a porcine bladder acellular matrix with well-preserved extracellular bioactive factors for tissue engineering. Tissue Eng Part C Methods 16: 1201-1211.
25. Deeken CR, White AK, Bachman SL, Ramshaw BJ, Cleveland DS, et al. (2011) Method of preparing a decellularized porcine tendon using tributyl phosphate. J Biomed Mater Res B Appl Biomater 96: 199-206.
26. Lu WD, Zhang M, Wu ZS, Hu TH, Xu ZJ, et al. (2010) The performance of photooxidatively crosslinked acellular bovine jugular vein conduits in the reconstruction of connections between pulmonary arteries and right ventricles. Biomaterials 31: 2934-2943.
27. Lu WD, Zhang M, Wu ZS, Hu TH (2009) Decellularized and photooxidatively crosslinked bovine jugular veins as potential tissue engineering scaffolds. Interact Cardiovasc Thorac Surg 8: 301-305.
28. Zhang R, Ma PX (1999) Poly(alpha-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. J Biomed Mater Res 44: 446-455. (Pubitemid 29031128)
29. Freytes DO, Badylak SF, Webster TJ, Geddes LA, Rundell AE (2004) Biaxial strength of multilaminated extracellular matrix scaffolds. Biomaterials 25: 2353-2361. (Pubitemid 38102389)
30. Wu S, Liu Y, Bharadwaj S, Atala A, Zhang Y (2011) Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering. Biomaterials 32: 1317-1326.
31. Lu WD, Wang AP, Wu ZS, Zhang M, Hu TH, et al. (2012) Calcification resistance for photooxidatively crosslinked acellular bovine jugular vein conduits in right-side heart implantation. J Biomed Mater Res A 100: 2644-2653.
32. Tudorache I, Cebotari S, Sturz G, Kirsch L, Hurschler C, et al. (2007) Tissue engineering of heart valves: biomechanical and morphological properties of decellularized heart valves. J Heart Valve Dis 16: 567-573; discussion 574.
33. Choi YC, Choi JS, Kim BS, Kim JD, Yoon HI, et al. (2012) Decellularized extracellular matrix derived from porcine adipose tissue as a xenogeneic biomaterial for tissue engineering. Tissue Eng Part C Methods 18: 866-876.
34. Bolland F, Korossis S, Wilshaw SP, Ingham E, Fisher J, et al. (2007) Development and characterisation of a full-thickness acellular porcine bladder matrix for tissue engineering. Biomaterials 28: 1061-1070. (Pubitemid 44816375)
35. Cartmell JS, Dunn MG (2000) Effect of chemical treatments on tendon cellularity and mechanical properties. J Biomed Mater Res 49: 134-140.
36. Woods T, Gratzer PF (2005) Effectiveness of three extraction techniques in the development of a decellularized bone-anterior cruciate ligament-bone graft. Biomaterials 26: 7339-7349. (Pubitemid 41133585)
37. Gratzer PF, Harrison RD, Woods T (2006) Matrix alteration and not residual sodium dodecyl sulfate cytotoxicity affects the cellular repopulation of a decellularized matrix. Tissue Eng 12: 2975-2983. (Pubitemid 46141262)
38. Chiu YC, Cheng MH, Engel H, Kao SW, Larson JC, et al. (2011) The role of pore size on vascularization and tissue remodeling in PEG hydrogels. Biomaterials 32: 6045-6051.
39. Mehdizadeh H, Sumo S, Bayrak ES, Brey EM, Cinar A (2013) Threedimensional modeling of angiogenesis in porous biomaterial scaffolds. Biomaterials 34: 2875-2887.
40. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, et al. (2005) Tensional homeostasis and the malignant phenotype. Cancer Cell 8: 241-254. (Pubitemid 41317594)
41. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, et al. (2009) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139: 891-906.
42. Moroni L, de Wijn JR, van Blitterswijk CA (2006) 3D fiber-deposited scaffolds for tissue engineering: influence of pores geometry and architecture on dynamic mechanical properties. Biomaterials 27: 974-985. (Pubitemid 41566689)
43. Trappmann B, Gautrot JE, Connelly JT, Strange DG, Li Y, et al. (2012) Extracellular-matrix tethering regulates stem-cell fate. Nat Mater 11: 642-649.
44. Liao J, Joyce EM, Sacks MS (2008) Effects of decellularization on the mechanical and structural properties of the porcine aortic valve leaflet. Biomaterials 29: 1065-1074. (Pubitemid 50020175)
45. Pagoulatou E, Triantaphyllidou IE, Vynios DH, Papachristou DJ, Koletsis E, et al. (2012) Biomechanical and structural changes following the decellularization of bovine pericardial tissues for use as a tissue engineering scaffold. J Mater Sci Mater Med 23: 1387-1396.
46. Williams C, Liao J, Joyce EM, Wang B, Leach JB, et al. (2009) Altered structural and mechanical properties in decellularized rabbit carotid arteries. Acta Biomater 5: 993-1005.
47. Minchinton AI, Tannock IF (2006) Drug penetration in solid tumours. Nat Rev Cancer 6: 583-592. (Pubitemid 44140857)
48. Meads MB, Gatenby RA, Dalton WS (2009) Environment-mediated drug resistance: a major contributor to minimal residual disease. Nat Rev Cancer 9: 665-674.
49. Fischbach C, Kong HJ, Hsiong SX, Evangelista MB, Yuen W, et al. (2009) Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc Natl Acad Sci U S A 106: 399-404.
50. De S, Razorenova O, McCabe NP, O'Toole T, Qin J, et al. (2005) VEGFintegrin interplay controls tumor growth and vascularization. Proc Natl Acad Sci U S A 102: 7589-7594. (Pubitemid 40741015)
51. Petersen TH, Calle EA, Colehour MB, Niklason LE (2012) Matrix composition and mechanics of decellularized lung scaffolds. Cells Tissues Organs 195: 222-231.
52. Mishra DK, Thrall MJ, Baird BN, Ott HC, Blackmon SH, et al. (2012) Human lung cancer cells grown on acellular rat lung matrix create perfusable tumor nodules. Ann Thorac Surg 93: 1075-1081.
53. Mishra DK, Sakamoto JH, Thrall MJ, Baird BN, Blackmon SH, et al. (2012) Human lung cancer cells grown in an ex vivo 3D lung model produce matrix metalloproteinases not produced in 2D culture. PLoS One 7: e45308.